Inotersen Sodium
Generic Name: inotersen sodium
Manufactured by AKCEA THERAPS. Dosage form: SOLUTION. Route: SUBCUTANEOUS. Active ingredients: INOTERSEN SODIUM (EQ 284MG BASE/1.5ML (EQ 189.3MG BASE/ML)). Application: NDA211172.
Overview
Manufactured by AKCEA THERAPS. Dosage form: SOLUTION. Route: SUBCUTANEOUS. Active ingredients: INOTERSEN SODIUM (EQ 284MG BASE/1.5ML (EQ 189.3MG BASE/ML)). Application: NDA211172.
Dosage
Available as solution for subcutaneous use.
Related Medications
Ps-2362 Hand Sanitizer 0.9g Packet
ps-2362 hand sanitizer 0.9g packet
Purpose Antiseptic Handwash
Aminocaproic Acid
aminocaproic acid
Antifibrinolytic Agent [EPC]
DESCRIPTION Aminocaproic acid is 6-aminohexanoic acid, which acts as an inhibitor of fibrinolysis. Its chemical structure is: Aminocaproic acid, USP is white or almost white crystalline powder or colorless crystals. It is freely soluble in water, slightly soluble in methanol, practically insoluble in acetone, hexane, methylene dichloride, and isopropyl alcohol.
Avelumab
avelumab
Programmed Death Ligand-1 Blocker [EPC]
11 DESCRIPTION Avelumab is a programmed death ligand1 (PD-L1) blocking antibody. Avelumab is a human IgG1 lambda monoclonal antibody produced in Chinese hamster ovary cells and has a molecular weight of approximately 147 kDa. BAVENCIO (avelumab) Injection for intravenous use is a sterile, preservative-free, non-pyrogenic, clear, colorless to slightly yellow solution. Each single-dose vial contains 200 mg avelumab in 10 mL (20 mg/mL).
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.